Xiaoli Wei Selected Research

oncrasin-1

4/2011	Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.
1/2011	Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoli Wei Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 02/2009
9	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2014
9	Glioma (Gliomas) 01/2018 - 11/2015
8	Glioblastoma (Glioblastoma Multiforme) 10/2017 - 04/2012
6	Brain Neoplasms (Brain Tumor) 01/2018 - 06/2012
5	Inflammation (Inflammations) 07/2022 - 02/2014
5	Infections 01/2022 - 01/2018
4	Non-alcoholic Fatty Liver Disease 07/2022 - 07/2012
4	Lung Neoplasms (Lung Cancer) 03/2021 - 06/2009
4	Fatty Liver 04/2016 - 01/2013
3	Bacterial Infections (Bacterial Infection) 01/2022 - 09/2017
3	Pain (Aches) 09/2020 - 08/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 01/2012
2	Obesity 07/2022 - 07/2012
2	Body Weight (Weight, Body) 01/2022 - 12/2007
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 11/2017
2	HIV Infections (HIV Infection) 01/2020 - 01/2019
2	Endotoxemia 04/2016 - 02/2015
2	Melanoma (Melanoma, Malignant) 02/2016 - 05/2014
2	Kidney Neoplasms (Kidney Cancer) 01/2011 - 04/2010
1	Otitis Media with Effusion 02/2022
1	Neutropenia 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Diabetes Mellitus 01/2022
1	Leukopenia 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Febrile Neutropenia 01/2022
1	Hyponatremia 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 10/2021

Drug/Important Bio-Agent (IBA)

16	Pharmaceutical PreparationsIBA 01/2022 - 09/2013
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2009
13	Peptides (Polypeptides)IBA 07/2020 - 01/2012
12	Liposomes (Liposome)IBA 10/2020 - 01/2012
10	LigandsIBA 01/2018 - 06/2012
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2013
6	Antineoplastic Agents (Antineoplastics)IBA 05/2013 - 06/2009
4	Contrast MediaIBA 07/2019 - 01/2016
4	IntegrinsIBA 01/2018 - 06/2012
4	Neuropilin-1IBA 12/2016 - 10/2013
4	NSC-741909IBA 01/2011 - 06/2009
3	LipidsIBA 07/2022 - 01/2013
3	Phosphotransferases (Kinase)IBA 01/2022 - 12/2010
3	Biological ProductsIBA 11/2021 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 08/2019 - 08/2017
3	GadoliniumIBA 07/2019 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2009
3	FructoseIBA 01/2018 - 09/2015
3	MicellesIBA 01/2018 - 06/2012
3	EnzymesIBA 10/2017 - 07/2012
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2016 - 06/2016
2	Therapeutic UsesIBA 02/2022 - 10/2013
2	Ethanol (Ethyl Alcohol)IBA 01/2022 - 04/2016
2	Dyneins (Dynein)IBA 10/2021 - 12/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2021 - 12/2010
2	Long Noncoding RNAIBA 01/2021 - 11/2017
2	MicroRNAs (MicroRNA)IBA 01/2021 - 08/2019
2	AntioxidantsIBA 09/2020 - 07/2012
2	VaccinesIBA 10/2019 - 10/2014
2	CopperIBA 01/2018 - 09/2015
2	polyethylene glycol- distearoylphosphatidylethanolamineIBA 10/2017 - 10/2014
2	cyclic arginine-glycine-aspartic acid peptideIBA 09/2017 - 06/2012
2	salinomycinIBA 08/2017 - 08/2017
2	Glutamic Acid (Glutamate)FDA Link 05/2017 - 08/2013
2	Pyruvate KinaseIBA 04/2017 - 02/2017
2	Tumor Biomarkers (Tumor Markers)IBA 04/2017 - 02/2017
2	IsoenzymesIBA 04/2017 - 02/2017
2	Cholinergic ReceptorsIBA 11/2016 - 11/2015
2	Nicotine FDA Link 11/2016 - 11/2015
2	PolymersIBA 11/2016 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 06/2016 - 08/2013
2	Triglycerides (Triacylglycerol)IBA 04/2016 - 01/2013
2	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 08/2015 - 06/2012
2	PolyethyleneimineIBA 08/2015 - 06/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2015 - 01/2013
2	oncrasin-1IBA 04/2011 - 01/2011
2	RNA Polymerase II (RNA Polymerase B)IBA 04/2011 - 01/2011
2	indoleIBA 12/2010 - 02/2009
1	Ambroxol (Mucosolvan)IBA 02/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Sincalide FDA Link 01/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Citric Acid (Citrate)FDA LinkGeneric 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	BuffersIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	graphene oxideIBA 03/2021
1	Gemcitabine FDA Link 03/2021
1	Reducing AgentsIBA 03/2021

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2012
4	Drug Therapy (Chemotherapy) 08/2019 - 06/2014
2	Aftercare (After-Treatment) 02/2022 - 06/2009
2	Intravenous Injections 01/2022 - 09/2020
2	Immunotherapy 07/2020 - 02/2016
2	Intravenous Administration 04/2016 - 04/2012
1	Photothermal Therapy 03/2021